Vialwirebiotech, curated
October 1, 2026, 3:52 AM
August 12, 2026
- 12:00 AM · FT — Pharmaceuticals12:00 AMHow AstraZeneca’s $400bn deal unravelled — FT — Pharmaceuticals
August 11, 2026
- 3:13 PM · SCMP — Tech3:13 PMFacebook parent Meta to unwind US$2 billion Manus AI deal after Beijing block — SCMP — Tech
- 12:12 PM · BioPharma Dive12:12 PMEx-Legend CEO takes helm at biotech startup scouring the globe for drugs — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAbcellera wows with phase II hot flash drug data — BioWorld
- 12:00 PM · BioWorld12:00 PMAlumis thesis in TYK2 holds true, psoriasis phase III LTE wins — BioWorld
- 12:00 PM · BioWorld12:00 PMTransthera wins NMPA nod for post-FGFR cholangiocarcinoma — BioWorld
- 12:00 PM · BioWorld12:00 PMFDA issues ITM Isotope’s ITM-11 a CRL for GEP-NETs — BioWorld
- 12:00 PM · BioWorld12:00 PMVaderis grabs $152M series B for HHT phase III — BioWorld
- 9:40 AM · BioPharma Dive9:40 AMChasing Dupixent, a biotech aims to make better antibody drugs for eczema — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMRemedium Bio raises $10 million series A to advance platform — BioWorld
- 9:00 AM · BioWorld9:00 AMSpyre initiates SPY-772 program in hidradenitis suppurativa — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA clears IND for Ribox’s RXIM-002 for autoimmune cytopenias — BioWorld
- 9:00 AM · BioWorld9:00 AMNewco news: Infinimmune takes another shot at IL-22 with $75M series A — BioWorld
- 9:00 AM · BioWorld9:00 AMAcurx and Leiden University enter new antibiotic partnership — BioWorld
- 8:00 AM · BioPharma Dive8:00 AMEpicrispr lands $90M to advance epigenetic editing drug for rare muscle disease — BioPharma Dive
- 7:43 AM · BioPharma Dive7:43 AMTrump signs order seeking to upend childhood vaccine schedule — BioPharma Dive
- 6:25 AM · Pharmaceutical Technology6:25 AMBMS banks on Texas for $2.3bn multi-modal manufacturing facility — Pharmaceutical Technology
- 5:45 AM · Pharmaceutical Technology5:45 AMBeOne and Revolution Medicines partner for oncology therapies — Pharmaceutical Technology
- 4:49 AM · Pharmaceutical Technology4:49 AMJazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront — Pharmaceutical Technology
- 4:30 AM · STAT News
- 4:00 AM · Drug Discovery World4:00 AMMindMaze Therapeutics refocuses efforts on neurology — Drug Discovery World
August 10, 2026
- 8:00 PM · Nature Biotechnology8:00 PMPrime prevails in Beam dispute — Nature Biotechnology
- 12:00 PM · BioWorld12:00 PMBiomarin eyes Amicus synergy as it cuts Inozyme rare disease ERT — BioWorld
- 12:00 PM · BioWorld12:00 PMTenax’s shares anything but ‘Level’ after failed phase III — BioWorld
- 11:44 AM · Drug Discovery World11:44 AMBase editing to enable single-base genomic changes — Drug Discovery World
- 11:25 AM · BBC — Health11:25 AMNew weight loss pill approved for use in UK — BBC — Health
- 11:11 AM · STAT News
- 10:25 AM · BioPharma Dive10:25 AMScribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses — BioPharma Dive
- 10:15 AM · Drug Discovery World10:15 AMAscendis provides update on achondroplasia programmes — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMAstronautx exercises option under Saniona neurology collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMCSPC announces IND approval for mpox mRNA vaccine SYS-6037 — BioWorld
- 9:00 AM · BioWorld9:00 AMPheast’s PHST-001 targets CD24 to boost antitumor immunity — BioWorld
- 9:00 AM · BioWorld9:00 AMOculis signs asset purchase agreement with Accure Therapeutics — BioWorld
- 8:03 AM · STAT News
- 7:14 AM · Pharmaceutical Technology7:14 AMSobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III — Pharmaceutical Technology
- 5:44 AM · Pharmaceutical Technology5:44 AMInnovent and Daiichi Sankyo sign deal for Vanflyta in China — Pharmaceutical Technology
- 4:41 AM · Pharmaceutical Technology4:41 AMEnergenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs — Pharmaceutical Technology
- 4:30 AM · STAT News
- 4:00 AM · Drug Discovery World4:00 AMNew therapy targets blocks to immunotherapy success in solid tumours — Drug Discovery World